Minerva Neurosciences, Inc. beat EPS estimates 0% of the time across 1 reported quarters (0 beats, 1 misses), averaging -30.8% versus consensus. Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result | Call |
|---|---|---|---|---|---|
| Q2 FY26 | not reported | $-0.46 | not reported | not reported | |
| Q1 FY26 | $-0.13 | $-0.17 | -30.8% | Miss | |
| Q4 FY25 | not reported | $-0.64 | not reported | not reported |
Back to NERV overview · NERV holders · NERV KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.